Brief: Vivoryon Therapeutics Announces Proposed Appointment Of Frank Weber As Chief Executive Officer
04/08/2023 22:32
Aug 4 (Reuters) - Vivoryon Therapeutics NV 05Y.F :
* VIVORYON THERAPEUTICS N.V. ANNOUNCES PROPOSED APPOINTMENT
OF DR.
FRANK WEBER AS CHIEF EXECUTIVE OFFICER
* VIVORYON THERAPEUTICS NV SAYS WEBER, WILL ASSUME CURRENT
CEO DR.
ULRICH DAUER'S RESPONSIBILITIES EFFECTIVE AUGUST 14, 2023
* VIVORYON THERAPEUTICS NV SAYS DAUER WILL SUPPORT COMPANY
THROUGH
TRANSITION PERIOD IN AN ADVISORY ROLE THROUGH END OF 2023
Source text for Eikon: ID:nGNE3G9N0T
Further company coverage: 05Y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivoryon Therapeutics NV
See all newsEurope Research Roundup: Colonial, Covivio SA, Fluidra SA
Brief: Vivoryon Therapeutics Says VIVIAD Phase 2B Study Does Not Meet Primary Endpoints
Brief: Vivoryon Reports Positive Outcome To Proceed With Alzheimer Drug Study
Jefferies starts Vivoryon at 'buy' on positive risk/reward from Alzheimer's pill
Brief: Vivoryon Therapeutics Announces Proposed Appointment Of Frank Weber As Chief Executive Officer